2007
DOI: 10.1016/s1063-4584(07)61432-0
|View full text |Cite
|
Sign up to set email alerts
|

P77 Major osteochondral defect (ICRS 4) treated with autologus bone marrow mononuclear cell Fraction in a collagen type II extracellular matrix

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2009
2009
2009
2009

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…The osteogenic differentiation was evaluated by alkaline phosphatase histochemistry and the chondrogenioc differentiation was evaluated by Western blot for collagen II ( Figure 2 ). We demonstrated that was possible to obtain MSCs by density gradient in a surgical room and these MSCs had osteogenic and chondrogenic capacity 7 .…”
Section: Molecular Approachmentioning
confidence: 97%
See 2 more Smart Citations
“…The osteogenic differentiation was evaluated by alkaline phosphatase histochemistry and the chondrogenioc differentiation was evaluated by Western blot for collagen II ( Figure 2 ). We demonstrated that was possible to obtain MSCs by density gradient in a surgical room and these MSCs had osteogenic and chondrogenic capacity 7 .…”
Section: Molecular Approachmentioning
confidence: 97%
“…The 2 patients with talus lesions improved the articular functionality according with AOFAS score in 37 points without evidences of progression of the osteochondral defects. These results were presented in congress and are being written to be sent for publication 8 , 9 . 4 years ago a 30 years old patient was diagnosed with an autoimmune disease and underwent cronic corticosteroid therapy.…”
mentioning
confidence: 97%
See 1 more Smart Citation